Skip to main content
Daphne Friedman, MD, Oncology, Durham, NC

DaphneFriedmanMD

Oncology Durham, NC

Hematologic Oncology

Medical Instructor in the Department of Medicine, Duke University School of Medicine

Dr. Friedman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Friedman's full profile

Already have an account?

  • Office

    2100 Erwin Rd
    Durham, NC 27705
    Phone+1 919-684-8111

Education & Training

  • Duke University Hospital
    Duke University HospitalFellowship, Hematology and Medical Oncology, 2005 - 2008
  • University of Maryland
    University of MarylandResidency, Internal Medicine, 2002 - 2005
  • University of Maryland School of Medicine
    University of Maryland School of MedicineClass of 2002

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 2005 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • SET Alpha and SET Beta mRNA Isoforms in Chronic Lymphocytic Leukaemia  
    Danielle M Brander, J Brice Weinberg, Daphne R Friedman, Thomas J Kipps, British Journal of Haematology

Lectures

  • Implementation of the VA Symptom Assessment Scale (VSAS): Five-year experience. 
    2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

  • Expanding Cancer Clinical Trial Access at VA
    Expanding Cancer Clinical Trial Access at VAJuly 20th, 2021
  • With TeleOncology, VA Stands Shoulder-to-Shoulder with Veterans in Rural Areas to Reduce Disparities in Cancer Care
    With TeleOncology, VA Stands Shoulder-to-Shoulder with Veterans in Rural Areas to Reduce Disparities in Cancer CareJuly 16th, 2021
  • TG Therapeutics, Inc. Announces Data Presentations at the Upcoming 59th American Society of Hematology Annual Meeting
    TG Therapeutics, Inc. Announces Data Presentations at the Upcoming 59th American Society of Hematology Annual MeetingNovember 1st, 2017